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Abstract
Lactic acid bacteria play an essential role in many food fermentation processes. They are anaerobic organisms
which obtain their metabolic energy by substrate phosphorylation. In addition three secondary energy transducing
processes can contribute to the generation of a proton motive force: proton/substrate symport as in lactic acid excre-
tion, electrogenic precursor/product exchange as in malolactic and citrolactic fermentation and histidine/histamine
exchange, and electrogenic uniport as in malate and citrate uptake in Leuconostoc oenos. In several of these process-
es additional H+ consumption occurs during metabolism leading to the generation of a pH gradient, internally
alkaline. Lactic acid bacteria have also developed multidrug resistance systems. In Lactococcus lactis three toxin
excretion systems have been characterized: cationic toxins can be excreted by a toxin/proton antiport system and
by an ABC-transporter. This cationic ABC-transporter has surprisingly high structural and functional analogy with
the human MDR1-(P-glycoprotein). For anions an ATP-driven ABC-like excretion systems exist.
Abbreviations: pmf – proton motive force, smf: sodium ion motive force.
Introduction
Lactic acid bacteria are the most important bacteria
used in food fermentations. Examples are fermented
milk products, including cheese, fermented vegeta-
bles such as sauerkraut and soy sauce and fermented
sausages. They also play crucial roles in other fermen-
tation processes such as the production of wine. Many
of these fermentation processes date back to prehistoric
times. One of the first microbiologists who realised the
importance of lactic acid bacteria for the food industry
and who studied these bacteria extensively was M.W.
Beyerinck. In the beginning of this century he pub-
lished two classical papers on the industrial lactic acid
fermentation (Beyerinck 1901) and on the process of
lactic acid fermentation in milk (Beyerinck 1907). In
the last 15 years the research on lactic acid bacteria has
mainly intensified as a result of an European commu-
nity funded programme on lactic acid bacteria. This
research activity has supplied a wealth of information
about the systematics, genetics, physiology and fer-
mentation technology of lactic acid bacteria and has
led to a phase in which extensive manipulation of the
important traits is possible in a very controlled way.
The studies on the physiology of lactic acid bac-
teria have focussed mainly on the metabolic pathways
such as lactose fermentation, citrate metabolism and
protein degradation. These studies have led to the real-
isation that translocation processes across the cytoplas-
mic membrane of the bacteria are crucial and often the
rate controlling steps in metabolism. An example of
such a crucial transport step in metabolism is the role
of the oligopeptide transport system in the proteolysis
of casein during cheese production (Kunji et al. 1995).
Transport processes of amino acids, peptides and lac-
tose have been studied in detail and this information
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Figure 1. Schematic presentation of the transport processes in the
cytoplasmic membranes of bacteria.
has been extensively reviewed (Konings et al. 1989,
1994). One rather unexpected outcome of these stud-
ies is that transport processes turn out to play a crucial
role in survival under energy-limited conditions or in
environments in which toxic compounds are present.
This review will discuss a number of transport phe-
nomena which are important for survival of lactic acid
bacteria e.g. energy transduction by secondary trans-
port processes and multidrug resistance processes.
Energy transduction in bacteria
For all living cells it is essential to transduce energy
to a form that can be used to drive energy-requiring
processes such as the synthesis of macromolecules,
motility, uptake of solutes across the cytoplasmic mem-
brane, etc. This energy is termed metabolic energy.
There are in essence two forms of metabolic energy:
energy-rich phosphate bond intermediates with ATP
as the major representative and electrochemical ener-
gy stored in ion gradients, mainly proton or sodium-
ion gradients. These two forms of metabolic energy
can be obtained by substrate level phosphorylation
and by chemiosmotic free energy-conserving process-
es (Mitchell 1968). The free energy released in a partic-
ular enzymatic reaction is directly used in the process
of substrate level phosphorylation for the synthesis of
ATP, which functions as a universal molecular carrier
of metabolic energy. In chemiosmotic free energy con-
servation chemical, light or redox energy is converted
into electrochemical energy by coupling the chemical
reactions to vectorial translocation of ions across the
membrane. In most bacteria these ions are protons,
but in a number of bacteria sodium-ions are the major
coupling ions in energy transducing processes (Lolke-
ma et al. 1994). The systems which generate these
electrochemical ion gradients are the ‘primary trans-
port systems’ and the process is ‘primary metabolic
energy generation’ (Figure 1). The electron transfer
systems (respiratory chains, anaerobic electron trans-
fer systems, phototrophic light-driven electron transfer
systems) and the membrane-bound F0F1-ATPases are
the best studied representatives of primary transport
systems. The electrochemical gradient of a particular
ion exerts a force on these ions which is termed the
ion motive force, i.e. proton motive force (pmf) or
sodium ion motive force (smf). The membrane bound
electron transfer systems are mainly responsible for
pmf or smf generation in bacteria that can use light or
redox energy. In lactic acid bacteria the proton motive
force contributes to the forces involved in the transport
step of most secondary transport processes. The pmf is
composed of two components: an electrical potential
(	), and a chemical potential of protons (- ZpH;






Secondary transport systems convert the (electro)-
chemical energy of one solute into the (electro)-
chemical energy of another solute. They are classified
in three groups (Figure 1) (i) uniporters catalyse the
translocation of only one solute across the cytoplas-
mic membrane; (ii) symporters mediate the coupled
transport of two or more solutes in the same direction;
(iii) antiporters couple the movement of one solute
in one direction to the translocation of another solute
in the opposite direction. Usually, but not necessarily,
one of the solutes in the coupled translocation process
is a proton. The solutes which are transported by the
secondary transport systems can be neutral or negative-
ly or positively charged. Furthermore, the number of
protons translocated per solute can vary. Consequent-
ly, the forces which drive the translocation process-
es differ (see Figure 2). It should be emphasised that
the direction of net translocation is determined by the
direction of the driving force unless other regulatory
factors prevent such an action.
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Figure 2. Driving forces for three secondary transport processes.




represents the contribution of the chemical gradient of A across the
membrane in mV to the driving force of A. n represents the number
of translocated protons.
The generation of metabolic energy by secondary
transport processes
In proton-dependent symport and antiport systems the
pmf or one of its components is used to drive the accu-
mulation or extrusion of another solute (Poolman &
Konings 1993). In this way a chemical gradient of
the solute is generated which, at thermodynamic equi-
librium (total driving force = 0), will be equal and
opposite to the driving force supplied by the proton





) is equal, but opposite in sign, to
the driving force exerted by the components of the pmf.
If for some reason the chemical gradient of A exceeds
the driving force supplied by the proton motive force
the reversed process can occur and the solute gradient
will drive the process in the opposite direction. This
reversed transport will lead to the generation of a pmf.
Thus, in principle, the activity of a secondary transport
system can lead to the generation of a proton motive
force, which, subsequently, can drive other metabolic
energy-requiring processes such as ATP synthesis by
the membrane bound F0F1-ATPase. Studies in lactic
acid bacteria have revealed that these latter process-
es play an important role in the bioenergetics of these
organisms (Otto et al. 1980; Poolman 1990; Konings et
al. 1994, 1995; Lolkema et al. 1996). Substrate uptake
as well as product excretion can contribute to energy
conservation in the form of the proton motive force.
If the overall process involves the net translocation of
charge, the electrical potential across the membrane
will be affected; when protons are translocated the
Figure 3. Proton motive force generating secondary transport
processes.
pH-gradient across the membrane will be changed. In
several of the processes which will be discussed below
the transport process is followed by metabolism in the
cytoplasm of the accumulated solute (precursor). If in
this metabolism net protons are consumed, an addi-
tional generation of a pH will occur.
Excretion of lactic acid
One mechanism by which a pmf can be generated is
by electrogenic excretion of an end product in symport
with proton(s) (Figure 3). An example is found in the
excretion of lactic acid in lactic acid bacteria. During
glucose or lactose fermentation lactic acid is produced
that can be excreted via a secondary transport system.
The excretion process in Lactococcus lactis has been
studied in vivo (Otto et al. 1980; Ten Brink & Konings
1982; Ten Brink et al. 1985) and in membrane vesicles
(Otto et al. 1982) within the pH range 5 to 8. The appar-
ent pK of lactic acid is 3.9, and at high intracellular pH
values essentially all lactic acid is in the anionic form.
At high pH values the excretion process was found to
result in the generation of a membrane potential, inside
anto882.tex; 28/11/1996; 15:35; v.5; p.3
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negative. This shows that the process is electrogenic,
indicating that more than one proton is translocated per
lactate anion. At low pH values lactate excretion does
not generate a membrane potential. The excretion is an
electroneutral process and only one proton is translo-
cated per lactate anion. These observations indicate
that at high pH values lactate is excreted by a proton
symport system with two or more protons (Konings &
Booth 1981) while at low pH values excretion occurs
via the same transport system but with a proton/lactate
stoichiometry of one and/or by passive diffusion of the
undissociated lactic acid. The degradation of glucose
by the glycolytic pathway leads to the formation of lac-
tic acid (lactate anion plus one H+). Therefore, only
excretion of lactate in symport with two or more pro-
tons will lead to the generation of a pmf and contribute
to additional metabolic energy during the fermentation
process. The process in which excretion of metabolic
end-products via ion symport mechanisms results in
the generation of metabolic energy has been termed
‘energy recycling’ (Michels et al. 1979).
Decarboxylation processes
Several exchange systems in bacteria mediate the net
translocation of charge across the cytoplasmic mem-
brane which results in the generation of a membrane
potential. If, in addition, in the conversion of substrate
to product a proton is consumed the fermentation will
lead to an increase of the internal pH and,consequently,
to the formation of apH (Lolkema et al. 1995). Then,
the pathway generates a proton motive force consisting
of both a membrane potential and pH gradient (Figure
3). Most known examples of such pathways to date
are precursor/product exchange systems in combina-
tion with precursor decarboxylation. The best studied
examples of decarboxylation driven pathways in lactic
acid bacteria are malate/lactic acid exchange (malolac-
tic fermentation) in L. lactis (Poolman et al. 1991), his-
tidine/histamine exchange in Lactobacillus buchneri
(Molenaar et al. 1993) and citrate/lactate exchange (cit-
rolactic fermentation) in Leuconostoc mesenteroides
(Marty et al. 1995, 1996). These pathways are driven
by the decarboxylation reaction (G00 - 25 kJ/mol).
The translocation process is driven by the inwardly
directed substrate concentration gradient and the out-
wardly directed product concentration gradient. Both
gradients are maintained by the decarboxylation reac-
tion.
Malolactic fermentation is carried out by some
species of the genera Lactobacillus, Lactococcus, Leu-
conostoc and Pediococcus (Kunkee 1991). In this path-
way L-malate enters the cells and is subsequently
decarboxylated by malolactic enzyme to yield L-lactic
acid and carbon dioxide, after which the reaction prod-
ucts leave the cell (Figure 4A). As a consequence of
the pK differences of the carboxylic acid groups on the
substrate and products, the pathway results in alkalin-
ization of the medium. It has been shown for L. lactis
that L-malate utilization results in the formation of a
pmf that is sufficiently high to drive ATP synthesis via
the F0F1-ATPase (Poolman et al. 1991).
The decarboxylase catalyses the conversion of L-
malate into L-lactate in two steps. First, L-malate is
oxidatively decarboxylated to yield pyruvate while the
electrons are donated to NAD+ which is a cofactor
of the enzyme. In the second step, pyruvate which
remains bound to the enzyme, is reduced by NADH
to L-lactate. Recently, the structural gene coding for
the enzyme of Lactococcus lactis has been cloned and
sequence comparison shows that malolactic enzyme is
homologous to the malic enzymes that catalyse the con-
version of malate into pyruvate (Anasany et al. 1993).
The transport of L-malate has been characterized in
artificial membranes prepared from L. lactis IL1403
(mal+) and in isogenic mutants, that are defective in
either L-malate transport or L-malate decarboxylation
(Poolman et al. 1991). Membrane vesicles catalyse
unidirectional uptake of L-malate (either as Hmal 
uniport or mal2 /H+ symport) and L-malate/L-lactate
exchange (either Hmal /Hlac or mal2 /lac ). In both
cases a negative charge is translocated into the mem-
brane vesicle which results in the formation of a mem-
brane potential (inside negative). L-malate accumu-
lates inside the membrane vesicles in the presence of a
pH gradient because of deprotonation of the transport-
ed species in the more alkaline internal milieu. The
exchange of L-malate2  for L-lactic  acid is much
more rapid than L-malate2 /H+ symport, and the for-
mer reaction is likely to be most relevant under phys-
iological conditions of malolactic fermentation in L.
lactis. Since charge compensation in the decarboxyla-
tion reaction requires the consumption of a proton, the
cytoplasm is alkalinized relative to the outside medi-
um and a pH is formed. Thus, the free energy of
the decarboxylation reaction is converted into a pmf
simply by compartmentalization of the malolactic fer-
mentation pathway, i.e. stoichiometric uptake of L-
malate2  and excretion of L-lactic  into the medium
combined with decarboxylation in the cytoplasm.
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Figure 4. Proton motive force generation by malolactic fermentation
in A. Lactococcus lactis and B. Leuconostoc oenos.
Histidine decarboxylation. Lactobacillus buchneri
decarboxylates histidine to the biogenic amine hista-
mine, which is excreted into the medium (Molenaar
et al. 1993). The pK
A
’s of the imidazole ring of histi-
dine and histamine are 6.0 and 5.8, respectively, and
the protonation state of the side chain of both mole-
cules will have a similar dependency on pH. However,
histamine carries one additional positive charge which
makes the histidine/histamine exchange electrogenic,
resulting in the net movement of a positive charge to
the outside. A pH is formed in a similar manner as
observed for malolactic fermentation.
Citrolactic fermentation. Cometabolism of glucose
and citrate by the lactic acid bacterium Leuconostoc
mesenteroides results in a growth advantage relative to
growth on glucose alone. Citrate is taken up by a sec-
ondary transporter, the product of the citP gene and,
subsequently, converted to oxaloacetate and acetate
by citrate lyase. Oxaloacetate is decarboxylated by the
cytoplasmic enzyme oxaloacetate decarboxylase yield-
ing CO2 and pyruvate. Pyruvate from citrate promotes
a metabolic shift in the heterofermentative pathway
for glucose breakdown yielding additional ATP which
usually is put forward to explain the increased growth
properties (Cogan 1987; Hugenholtz 1993; Lin et al.
1991; Schmitt et al. 1990). In the absence of citrate,
acetyl-P formed from glucose is reduced to ethanol
which balances the redox equivalents produced in the
other steps of the phosphoketolase pathway. In the
presence of citrate, the redox equivalents are shuttled
to pyruvate produced from citrate, yielding D-lactate
and acetyl-P is converted into acetate via the acetate
kinase pathway which results in the production of ATP.
Recent studies have demonstrated that citrate break-
down in Lc. mesenteroides is a secondary metabolic
energy generating pathway which provides an addi-
tional explanation for the growth enhancement (Marty-
Teysset et al. 1995, 1996; Lolkema et al. 1996). Citrate
enters the cell in exchange with D-lactate that is pro-
duced inside the cell as an end product during glu-
cose/citrate cometabolism (citrolactic fermentation).
The exchange is electrogenic and translocates nega-
tive charge into the cell thereby generating a mem-
brane potential. The pathway as a whole is alkaliniz-
ing and results in a pH gradient, inside alkaline, over
the cell membrane. Therefore, citrate metabolism in
Lc. mesenteroides results in the generation of a proton
motive force that consists of both a membrane potential
and pH gradient.
Uniport systems. Studies of malate and citrate
metabolism in Leuconostoc oenos have revealed that a
proton motive force can also be generated by electro-
genic uniport of a negatively charged substrate (Fig-
ure 3). L. oenos grows at more acidic pH values than
for instance Lactococcus lactis. Malolactic fermenta-
tion, in this bacterium proceeds through the uptake
of negatively charged mono-protonated Hmalate  by
a uniport mechanism rather than by Hmalate /Hlac
(or mal2 /lac ) exchange (Figure 4B). Lactic acid
formed in the proton consuming decarboxylation reac-
tion leaves the cell by passive diffusion. Energetically,
the result is the same, i.e. generation of a membrane
potential and pH gradient. Again, the whole pathway
is driven by the decarboxylase. The difference is in the
transporter that in case of the uniport is only dirven
by the substrate concentration gradient. Therefore, it
is essential that a high solute concentration gradient is
maintained by keeping the internal concentration of the
solute low by rapid internal metabolism (Salema et al.
1994, 1996). The different physiological functions of
the malate carriers of L. lactis and Lc. oenos are reflect-
ed in the kinetic properties of the transporters. In L.
lactis malate/lactate exchange is catalysed much more
efficiently than unidirectional uptake. In Lc. oenos the
opposite is true.
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Surprisingly, studies of citrate transport in isolat-
ed membrane vesicles of Lc. oenos showed the same
mechanism as observed for malate uptake (Ramos et
al. 1994). The citrate carrier catalyses uniport of mono-
valent H2cit  implying that citrate metabolism by Lc.
oenos is involved in the generation of a membrane
potential. Citrate metabolism in citrate-fermenting lac-
tic acid bacteria results in alkalinization of the medium,
i.e. protons are consumed in the metabolic breakdown
inside the cell and a pH gradient is formed. Therefore,
citrate metabolism in Lc. oenos is predicted to gener-
ate a proton motive force consisting of a membrane
potential generated during the electrogenic uptake of
H2cit  and a pH gradient generated by the consump-
tion of scalar protons in the further degradation of
citrate inside the cell. Studies with resting cells of
Lc. oenos confirmed the prediction made based on the
studies with the membrane vesicles. Addition of citrate
to the cells resulted in the generation of both a mem-
brane potential and pH gradient independent of F0F1
H+-ATPase activity.
Multidrug resistance
Toxic compounds have always been part of the natural
environments of bacteria. The development of versa-
tile mechanisms to resist antibiotics and other cytotoxic
drugs has been crucial for the survival of the organisms
(Lewis 1994; Nikaido 1994). An important group of
resistance mechanisms is found in the specific drug
resistance systems (SDR) and the multidrug resistance
systems (MDR). These systems prevent the entrance of
specific (SDR) or a variety (MDR) of toxic compounds
into the cell by actively transporting the compounds out
of the cell. MDR systems from eukaryotic organisms
are studied extensively for reason that these systems
cause resistance of carcinoma cells against chemother-
apeutic agents (Simon & Schindler 1994). In bacteria
both SDR and MDR systems are subject to extensive
research since these systems are often responsible for
the antibiotic resistance of pathogenic bacteria (Hayes
& Wolf 1990).
In L. lactis three multidrug resistance systems have
been discovered. One system confers resistance against
anionic compounds; the other two systems are cation
excretion systems (Van Veen et al. 1996a). On the
basis of bioenergetic and structural criteria these trans-
port systems can be divided into: (i) secondary drug
transporters and (ii) ATP-binding cassette (ABC)-type
drug transporters. The secondary transporters are sin-
gle membrane proteins which mediate the extrusion
of the drug in a coupled exchange with protons or
sodium-ions (Poolman & Konings 1993). They are
divided into two groups: (i) TEXANs (Toxin EXtrud-
ing ANtiporters) which have 12 to 14 transmembrane
-helical domains and (ii) Mini TEXANs with only
4 transmembrane -helical domains (Schuldiner et
al. 1995). The ABC-type drug transporters belong to
the ABC superfamily, the members of which all con-
tain a highly conserved ATP-binding cassette (Hig-
gins 1992; Van Veen et al. 1996b). They utilize the
energy released by ATP-hydrolysis to pump cytotox-
ic compounds out of the cell. Typically, ABC trans-
porters require the function of four protein domains
(Higgins 1992; Fath & Kolter 1993). Two of these
domains are highly hydrophobic and consist each of six
putative transmembrane -helices. These hydropho-
bic domains form the path through which the sub-
strate crosses the membrane. The other two domains
are attached to the membrane at the cytoplasmic side.
These domains bind ATP and couple ATP-hydrolysis
to the translocation of the substrate (Dean et al. 1989;
Amres et al. 1989).
Multidrug resistance in L. lactis
Extrusion of cations
L. lactis subsp. lactis MG1363 was found to be resis-
tant to a number of toxic compounds such as ethidium
bromide, daunomycin and rhodamine 6 G. To study
this resistance phenomenon in detail mutant strains of
L. lactis were isolated with resistance to high con-
centrations of these drugs. These mutants which were
obtained by growing the organism on increasing con-
centrations of these toxic compounds, were termed
EthR, DauR and RhoR, respectively (Bolhuis et al.
1994). These mutants were found to be cross resistant
to a number of structurally and functionally unrelated
drugs, among which are typical substrates for the mam-
malian multidrug transporter (MDR 1, P-glycoprotein)
such as daunomycin, quinine, actinomycin D, grami-
cidin D and rhodamine 6G. Each of the multidrug resis-
tant strains showed an increased resistance against the
other two compounds for which resistant mutants were
selected (Bolhuis et al. 1994). Furthermore, all three
strains showed an increased rate of energy-dependent
ethidium and daunomycin efflux compared to that of
the wild-type strain and this efflux was drastically
inhibited by the P-glycoprotein inhibitor reserpine.The
energetics of the efflux process was analysed by study-
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Figure 5. Secondary structure models of two drug extrusion systems in Lactococcus lactis. A. the toxin/proton antiport system LmrP and B. the
ABC-drug extrusion system LmrA.
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ing the effects on the efflux process of the pmf dis-
sipating ionophores, valinomycin and nigericin, and
the ABC transporter inhibitor ortho-vanadate. Ethidi-
um efflux in the EthR strain was inhibited by ortho-
vanadate and not by dissipation of the pmf, while both
inhibitors decreased partially the efflux of ethidium
in DauR and RhoR strains. From these results it was
concluded that two cationic multidrug excretion sys-
tems are present in L. lactis: one which is pmf driven
and a second one which is mainly present in the EthR
strain and is ATP-dependent (Bolhuis et al. 1994). The
energetic, genetic and biochemical properties of both
systems have been studied in detail.
The pmf dependent drug efflux system is encod-
ed by the lmrP gene, which encodes a hydrophobic
polypeptide of 408 residues (Bolhuis et al. 1995).
Hydropathy analysis suggest that this protein is com-
posed of 12 transmembrane -helices (Figure 5A).
When expressed in E. coli, LmrP convers resistance
to ethidium, daunomycin and tetraphenylphosphoni-
um. The drug efflux process in E. coli or L. lactis in
which LmrP was expressed, is driven by the pmf since
ethidium efflux is completely inhibited by a dissipation
of the pmf and is not affected by the ATPase inhibitor
ortho-vanadate. From these studies and those in E. coli
membrane vesicles containing LmrP protein (Bolhuis
et al. 1996b), it is concluded that LmrP catalyses drug-
proton antiport. It therefore belongs to the family of
TEXANs.
When the lmrP gene was deleted, the mutant strain
obtained still exhibited residual ethidium extrusion
activity, which in contrast to the parent strain was inhib-
ited by ortho-vanadate. This observation indicates that
in the absence of the functional drug-proton antiport
system LmrP, L. lactis is able to overexpress anoth-
er, ATP-dependent drug extrusion system. This system
was further characterised by cloning and functionally
expressing the gene in E. coli (Van Veen et al. 1996b).
The gene is designated lmrA and encodes for a protein
of 589 amino acids with a molecular weight of 64 kDa.
Hydropathy analysis of LmrA suggest the presence
of an N-terminal hydrophobic domain with 6 putative
transmembrane regions and a C-terminal hydrophilic
domain (Figure 5B). The C-terminal domain contains
the ATP-binding motif diagnostic of an ABC-type
transporter. Most surprisingly, the LmrA protein was
found to be very similar to the human P-glycoprotein
MDR1. This latter protein is about double the size
of LmrA (1280 amino acids) and is composed of
two homologous halves each with 6 transmembrane
regions and a large cytoplasmic loop containing the
Figure 6. Uptake of daunomycin in inside-out membrane vesicles
of Escherichia coli CS1562 (open symbols) and the strain in which
LmrA was expressed (closed symbols). Uptake studies were done
in the presence of valinomycin and nigericin (each at 1 nmol/mg of
protein) and 1 mM ATP plus 0.1 mg/ml creatine kinase (N, M) or
1 mM non-hydrolysable ATPS ( ,#).
ATP-binding site. At the amino acid sequence level
each half of P-glycoprotein has 48% similarity with
LmrA.
Expression of LmrA in E. coli resulted in an
increased resistance of the organism against ethidium,
daunomycin, rhodamine 6G and tetraphenyl phospho-
nium. The E. coli cells also excreted ethidium when
glucose was added to cells which had previously accu-
mulated ethidium in the absence of an energy source.
Direct evidence that LmrA is an ATP-dependent drug
extrusion system is obtained by studies in inside-out
membrane vesicles from E. coli cells in which LmrA
was expressed. In the presence of ATP but not in the
presence of a pmf these membrane vesicles accumulat-
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ed the substrates ethidium, daunomycin and ajmalini-
um, a high affinity substrate of P-glycoprotein (Figure
6). These results clearly identify LmrA as an ATP-
dependent multidrug extrusion system. It represents
the first example of a prokaryotic structural and func-
tional homologue of P-glycoprotein.
Extrusion of anions
Besides the TEXAN LmrP and the P-glycoprotein
homolog LmrA, L. lactis also possesses an ATP-
dependent multidrug extrusion system with specificity
for organic anions. This system was detected in cells
of L. lactis due to its ability to extrude the fluores-
cent pH indicator BCECF (20,70-bis-(2-carboxyethyl)-
5(and 6)-carboxyfluorescein) (Molenaar et al. 1991,
1992). BCECF efflux is directed against a concen-
tration gradient and strictly correlates with the cellu-
lar ATP concentration. In addition, BCECF efflux is
strongly decreased in the presence of ortho-vanadate,
a well known inhibitor of P-type ATPases and ABC
transporters. Most convincingly, a UV mutant with
a strongly reduced efflux rate could be isolated from
a BCECF-loaded and lactose-energized cell popula-
tion by selection of highly fluorescent cells in a flow
cytometer-cell sorter (Molenaar et al. 1992). Studies
in inside-out membrane vesicles of L. lactis have indi-
cated that the BCECF transporter is not only able to
transport carboxyfluorescein derivatives, but also glu-
tathione conjugates such as dinitrophenyl-glutathione
(Van Veen et al. 1996a). Interestingly, the substrate
specificity of the BCECF transporter of L. lactis is
remarkably similar to that of the human multidrug
resistance-associated protein (MRP) (Mu¨ller et al.
1994; Leier et al. 1994; Zaman et al. 1994). The over
expression of this ABC transporter in human cancer
cells results in a P-glycoprotein-independent multidrug
resistance phenotype. In hepatocytes, MRP plays a role
in a glutathione S-transferase-dependentdetoxification
pathway for electrophilic drugs, and in the excretion
of oxidized glutathione (GSSG) during oxygen stress
(Ishikawa 1992). The BCECF transporter of L. lactis
may have functions similar to those of MRP. Although
L. lactis contains a manganese-dependent superoxide
dismutase to detoxify oxygen radicals, the enzyme is
not essential for the aerotolerance of this fermentative
bacterium (Sanders et al. 1995). An alternative protec-
tion mechanism against oxygen damage may be based
on the detoxification of oxygen radicals by reduced
glutathione (Meister 1988). This compound is present
at high concentrations in L. lactis and other facultative
anaerobic bacteria (Fahey et al. 1978). During oxygen
stress, optimal levels of reduced versus oxidized glu-
tathione may be maintained through the excretion of
GSSG via the BCECF transporter.
Molecular models of multidrug transport
Several models have been postulated for the pump
function of multidrug transporters to explain their
broad specificity for chemically unrelated compounds.
Drug translocation may involve substrate transport
from the cytoplasm to the exterior which would require
an enormous flexibility of an ‘enzyme-like’ substrate
recognition site (conventional transport hypothesis)
(Altenberg et al. 1994; Mu¨lder et al. 1993). Alter-
natively, multidrug transporters could recognize the
lipophilic drugs by their physical property to interca-
late into the lipid bilayer, and transport drugs from the
lipid bilayer to the exterior (vacuum cleaner hypothe-
sis) (Raviv et al. 1990), or from the inner leaflet to the
outer leaflet of the lipid bilayer (flippase hypothesis)
Higgins & Gottesman 1992; Higgins 1994).
Cells expressing LmrA were found to active-
ly extrude the hydrophobic acetoxymethyl ester of
BCECF (Bolhuis et al. 1996a). Similar observations on
the human multidrug resistance P-glycoprotein were
taken as evidence for the transport of hydrophobic
compounds from the plasma membrane (Homolya et
al. 1993). The transport mechanism of LmrA has been
studied in greater detail by using the amphiphilic, flu-
orescent membrane probe TMA-DPH. Intercalation of
TMA-DPH in the phospholipid bilayer is based on a
fast partitioning of the probe in the outer leaflet, fol-
lowed by a slower transbilayer movement of the probe
from the outer to the inner leaflet of the membrane. The
correlation between the initial TMA-DPH extrusion
rate and the amount of TMA-DPH associated with the
inner membrane leaflet, suggests that LmrA transports
TMA-DPH from the inner leaflet of the cytoplasmic
membrane (Bolhuis et al. 1996a). Thus, LmrA recog-
nizes drugs by their hydrophobic properties as sug-
gested by the ‘flippase’ and ‘vacuum cleaner’ models.
Identical observations were made for LmrP mediated
TMA-DPH transport in whole cells and in inside out
membrane vesicles of Escherichia coli, suggesting a
similar mechanism of drug extrusion by the secondary
drug transporter of L. lactis (Bolhuis et al. 1996b).
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Figure 7. The three characterised multidrug resistance systems in
Lactococcus lactis.
Conclusions
Lactic acid bacteria are considered to be rather sim-
ple organisms with limited physiological capacities.
However, they have developed ingenious systems for
extracting as much metabolic energy from their sub-
strates as possible. Three classes of transport systems
can play a role in this metabolic energy generation:
symporters, antiporters and uniporters (Figure 3). The
activity of these systems allow the lactic acid bacteria
to survive under energy limited conditions.
Lactic acid bacteria have also developed extensive
protection mechanisms against toxic compounds. In
Lactococcus lactis three systems have been character-
ized: 2 against cationic compounds and one against
anionic compounds (Figure 7).
These systems protect the organisms against toxic
compounds in the environment, but they also might
play a role in excreting toxic compounds produced
during metabolism.
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